Globalization

iCardiac collaborating with Japanese SMO to conduct cardiac safety studies

19-Sep-2016 By Melissa Fassbender

iCardiac Technologies and SNBL CPC Japan, a Japanese-based Site Management Organization (SMO), will collaborate on cardiac safety studies in the country.

Marken expands capabilities with new pharma license at Moscow depot

24-Aug-2016 By Melissa Fassbender

Marken’s Moscow-based depot has been granted a new pharmaceutical license from the Russian Federation, further extending the company’s capabilities in the area.

Ash Stevens acquired by India-based CDMO

16-Aug-2016 By Melissa Fassbender

Ash Stevens has been acquired by Piramal Pharma Solutions, an India-based CDMO, in what the CEO said is an "incredibly powerful combination."

DIA 2016

'Now is the time to include Japan' says Parexel

24-Jun-2016 By Melissa Fassbender

Japan “welcomes innovation” as it makes significant investments in infrastructure and regulatory changes.

INC Research expands in Japan amid 'evolution of the clinical trial landscape'

30-May-2016 By Melissa Fassbender

The CRO has opened new offices in Japan as part of its long-term growth strategy in the country – the world’s second largest pharmaceutical market.

ClinTec 'on track' with growth strategy as new offices open in Spain

26-May-2016 By Melissa Fassbender

ClinTec International has opened two new offices in Spain as it prepares for an expanding local clinical trial portfolio and larger outsourcing engagements in the country.

Famar set to step into North America by buying Quebec plant from Bayer

18-Apr-2016 By Dan Stanton

European CDMO Famar says it will continue making products on behalf of Bayer after acquiring a Canadian manufacturing facility from the firm.

Mexico office to bolster CRO Eurotrials' presence in Latin America

17-Mar-2016 By Dan Stanton

Eurotrials has opened an office in Mexico City in a bid the dominant CRO in the growing Mexican clinical research market.

Eurofins expands into Asia-Pacific through QC services firm acquisition

14-Mar-2016 By Dan Stanton

Eurofins has bought Australian QC firm ams Laboratories in a push to expand its biopharma testing services into the Asia-Pacific region.

Catalent bringing clinical supply services to Japanese facility

21-Jan-2016 By Dan Stanton

Catalent will expand its cGMP facility in Japan to bring secondary packaging and clinical supply services to the region.

India has 'natural potential to grow' in CRO space, says Syngene CEO

14-Jan-2016 By Dan Stanton

India’s CRO industry is playing catch-up to the generic and manufacturing sectors, according to the departing CEO of one of the largest players, Syngene.

PRA and newly private WuXi call time on China JV

11-Dec-2015 By Dan Stanton

WuXi PharmaTech and PRA Health Sciences have ended a three year clinical trial management partnership in China.

Megamerger Pfall-out? $160bn Pfizer-Allergan deal to hit CROs in short-term, analysts

24-Nov-2015 By Dan Stanton

The $160bn Pfizer-Allergan megamerger could lead to booking cancellations in the short-term say analysts, but CROs – especially Icon, Parexel and PPD - should ultimately benefit.